11/06/2026
Six years after the start of COVID-19, are we better prepared for another pandemic?
For plasma-derived therapies, supply chain resilience remains a critical challenge. Our latest blog explores what COVID-19 revealed about the plasma industry, the vulnerabilities that still exist, and what can be done to strengthen preparedness for the future.
Read more: https://loom.ly/fM3qNcI